Cytokinetics
CYTK
#2487
Rank
NZ$12.98 B
Marketcap
NZ$93.22
Share price
-0.64%
Change (1 day)
-20.26%
Change (1 year)

Earnings for Cytokinetics (CYTK)

Earnings in 2026 (TTM): -NZ$1.37 Billion

According to Cytokinetics 's latest financial reports the company's current earnings are NZ$0.11 Billion. In 2025 the company made an earning of -NZ$1.43 Billion a decrease over its 2024 earnings that were of -NZ$1.08 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytokinetics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$1.37 Billion-4.51%
2025 -NZ$1.43 Billion33.15%
2024 -NZ$1.08 Billion12.03%
2023 -NZ$0.96 Billion35.3%
2022 -NZ$0.71 Billion80.65%
2021 -NZ$0.4 Billion69.15%
2020 -NZ$0.24 Billion4.6%
2019 -NZ$0.23 Billion14.49%
2018 -NZ$0.2 Billion-16.83%
2017 -NZ$0.24 Billion-812.8%
2016 NZ$32.56 M-147.81%
2015 -NZ$68.12 Million156.05%
2014 -NZ$26.61 Million-56.56%
2013 -NZ$61.25 Million-16.48%
2012 -NZ$73.33 Million-15.65%
2011 -NZ$86.94 Million-3.24%
2010 -NZ$89.85 Million-308.68%
2009 NZ$43.05 M-141.87%
2008 -NZ$0.11 Billion0.21%
2007 -NZ$0.11 Billion-7.91%
2006 -NZ$0.12 Billion37.42%
2005 -NZ$81.08 Million16.13%
2004 -NZ$69.82 Million-19.29%
2003 -NZ$86.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
NZ$20.07 B-1,520.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-NZ$56.42 Million-96.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.11 B-107.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-NZ$0.5 Billion-65.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-NZ$93.82 Million-93.36%๐Ÿ‡บ๐Ÿ‡ธ USA